Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Worldwide distribution rights of 2 specialty drugs. The rights allows production and sale of Buccastem, used for the treatment of nausea and vomiting, and Timodine, a anti-fungal and anti-bacterial skin cream used for treating inflamed and infected skin conditions.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- 103 - 105 Bath Road
- Slough SL1 3UH
- England, United Kingdom
Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)‘s full profile, request access.
Request full access to PitchBookReckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)‘s full profile, request access.
Request full access to PitchBook